Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

During the Trading Day
3.86 -0.10 / -2.53%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.86 -0.0008 / -0.02%
Volume: 120.3K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 2
Quarter 3
Quarter 4
Quarter 1
Revenue and IncomeNet Revenues857.0K30.9M23.0M4.4M
Depreciation And Amortization38.0K41.0K52.0K51.0K
Operating ExpensesGross Income----------
General Expenses23.6M17.8M20.5M19.8M
Research And Development16.7M10.7M13.0M11.2M
Total Operating Expenses23.7M17.8M20.6M19.8M
Non-Operating ExpensesOperating Income-22.8M13.0M2.4M-15.5M
Interest Expense On Debt1.7M1.8M1.8M1.8M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.5M11.3M607.0K-17.2M
Net Income-24.5M11.3M607.0K-17.2M
Shares To Calculate EPSShares To Calculate EPS118.0M122.6M123.0M123.9M
Shares To Calculate EPS Diluted118.0M130.1M123.0M123.9M
Earnings Per ShareEPS-$0.21$0.09$0.00-$0.14
EPS Diluted-$0.21$0.09$0.00-$0.14